National trends in radiation dose escalation for glioblastoma
Radiation Oncology Journal. 2019;37(1):13-21 
Feasibility of Extreme Dose Escalation for Glioblastoma Multiforme Using 4π Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics. 2014;90(1):S109
Pulsed Low-dose-rate Versus Standard Irradiation in Orthotopic Glioblastoma Multiforme: Dose-Escalation, Functional Imaging, and the Small Animal Radiation Research Platform
International Journal of Radiation Oncology*Biology*Physics. 2012;84(3):S696
A Phase I dose escalation trial of motexafin gadolinium (gadolinium texaphyrin, xcytrinR)as a radiation sensitizer in patients with newly diagnosed glioblastoma multiforme
International Journal of Radiation Oncology*Biology*Physics. 2001;51(3):205
Presentation of treatment effect in glioblastoma after dose-escalation radiation therapy
Oxford Medical Case Reports. 2019;2019(9):
Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapy
Radiation Oncology. 2014;9(1):
993 Poster Novel approaches for dose escalation in radiotherapy of glioblastoma: first clinical experience
Radiotherapy and Oncology. 2002;64:S292
Phase I/II conformal three-dimensional radiation therapy dose escalation study in patients with supratentorial glioblastoma multiforme: Report of the radiation therapy oncology group 98–03 protocol
International Journal of Radiation OncologyBiologyPhysics. 2004;60:S163-S164
A Phase I Study of Accelerated Radiotherapy for Glioblastoma Multiforme Using Stereotactic Concomitant Boosts for Dose Escalation
International Journal of Radiation Oncology*Biology*Physics. 2005;63:S265-S266
Phase 1 TITE-CRM Dose Escalation Study of Concurrent Temozolomide and Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme
International Journal of Radiation Oncology*Biology*Physics. 2009;75(3):S124